HealthLynked Corp
HLYKOTCCIK 1680139HealthcareFiscal year ends Dec 31
Reports and events: 107 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1416:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090221 |
| 2026-07-1616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-078695 |
| 2026-05-2916:39 ET | S-1/A | Registration statement, amended | 0001213900-26-062879 |
| 2026-05-1515:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057581 |
| 2026-04-3016:33 ET | S-1/A | Registration statement, amended | 0001213900-26-050297 |
| 2026-03-3116:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-037499 |
| 2026-02-1019:29 ET | S-1 | Registration statement | 0001213900-26-013824 |
| 2026-02-0616:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-013261 |
| 2025-12-1216:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-121170 |
| 2025-11-1915:29 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-112578 |
| 2025-09-0509:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-084743 |
| 2025-08-1416:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076656 |
| 2025-05-1516:18 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-044233 |
| 2025-03-3116:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026262 |
| 2025-03-2616:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001013762-25-002723 |
| 2025-02-0408:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-009700 |
| 2025-01-1516:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-003828 |
| 2024-11-1416:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098383 |
| 2024-09-2416:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-081421 |
| 2024-08-1416:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068949 |
| 2024-06-2616:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-056163 |
| 2024-06-0516:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-050045 |
| 2024-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-043561 |
| 2024-04-0116:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028696 |
| 2024-03-1416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-022598 |
| 2024-01-1115:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-002970 |
| 2023-12-2716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-098864 |
| 2023-11-1416:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086915 |
| 2023-08-1416:12 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-067049 |
| 2023-05-1516:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-039725 |
| 2023-03-3116:02 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-025432 |
| 2023-03-2116:05 ET | 8-K | 8.01 Other events | 0001213900-23-021776 |
| 2023-03-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-23-020304 |
| 2023-01-2316:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-004434 |
| 2022-11-1816:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-22-073863 |
| 2022-11-1416:09 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-072198 |
| 2022-10-1916:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-22-064963 |
| 2022-08-1516:35 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-048070 |
| 2022-07-2216:05 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-22-040974 |
| 2022-07-1116:36 ET | S-1 | Registration statement | 0001213900-22-038566 |
| 2022-07-0816:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-22-038237 |
| 2022-06-0316:00 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001213900-22-031122 |
| 2022-05-1916:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-028266 |
| 2022-05-1616:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-027072 |
| 2022-03-3116:08 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-016741 |
| 2021-11-1515:56 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-059301 |
| 2021-08-3017:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-045668 |
| 2021-08-1616:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-042938 |
| 2021-05-1716:09 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-026989 |
| 2021-04-2015:34 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001213900-21-022274 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.